Fierce Pharma

SEPTEMBER 28, 2023

Bluebird and Lonza recently amended their production contract for the second time since the deal was announced in summer of 2016. As bluebird bio’s pricey gene therapy launches take flight, the company is boosting manufacturing capacity with Swiss CDMO Lonza.

Manufacturing 240

Manufacturing 240

Fierce Pharma

JUNE 8, 2023

Novartis’ generics and biosimilars unit Sandoz—soon to be spun off as a stand-alone company—has seen a decline | Novartis’ generics and biosimilars unit Sandoz—soon to be spun off as a stand-alone company—has seen a decline in revenue every year since 2016.

Sales 246

Sales 246

pharmaphorum

JUNE 27, 2016

As a snapshot, 2014 saw 40,000 tweets and 140m+ impressions over the conference days, 2015 grew to 60,000 tweets and 250m+ impressions and the 2016 buzz is already louder and more plentiful than last year.

Media 52

Media Medical Pharma 52

Pharmaceutical Technology

NOVEMBER 10, 2022

Royalty Pharma has purchased a royalty interest in Amgen ’s small interfering ribonucleic acid (siRNA) therapy, olpasiran, from Arrowhead Pharmaceuticals for an upfront payment of $250m in cash. In 2016, it was licensed by the company to Amgen.

Pharma 52

Pharma Sales Pharmaceutical Patients 52

Pharmaceutical Technology

NOVEMBER 8, 2022

Fulgent Genetics has acquired clinical-stage therapeutics development firm Fulgent Pharma for a total deal price of nearly $100m. Until 2016, Fulgent Therapeutics owned both Fulgent Pharma and Fulgent Genetics. Fulgent Pharma focuses on developing cancer therapies.

Pharma 52

Pharma Marketing Medicine Leads 52

World of DTC Marketing

MARCH 6, 2022

A 2016 study reported that 259,000 digital health apps were available for consumers. A record number (296) of private digital health companies received venture funding in 2016, funding that totaled more than $4.2 Maybe, however, they should check with patients first. billion that year and approached $6 billion the following year.

Patients 244

Patients Doctors Leads FDA 244

Clarivate

MAY 31, 2023

A glance at the 2022 top selling drugs for the biggest pharma companies reveals how dependent many large pharmas are on a small basket of products – most acquired through partnerships or acquisitions – that are nearing loss of exclusivity. Pharma is placing bigger bets on a smaller number of therapeutics and technology platforms.

Pharma 52

Pharma Biopharma Medicine Competition 52

Pharma Marketing Network

DECEMBER 17, 2021

Big pharma has compelling reasons to change the way business gets done. Johnson & Johnson was one of the first major companies to make a public commitment to the SDGs in 2016. What is Big Pharma doing to tackle climate change? Adding sustainable procurement to your ESG efforts widens its reach and impact. Sunny White.

Pharma 103

Pharma Ethics Recruitment Government 103

PM360

JUNE 26, 2023

Expanding Opportunities for Pharma Companies in Emerging Markets Despite these challenges, pharmaceutical companies have excellent reasons to launch their products in emerging markets. This can result in shareholders’ resentment, negatively impacting the valuation of the manufacturing company. In a shareholder meeting, Merck & Co.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

European Pharmaceutical Review

MARCH 8, 2023

To mark International Women’s Day, EPR talked to Dr Ekaterina Malievskaia, Chief Innovation Officer and Co-founder of COMPASS Pathways about her inspiration, the challenges as a woman working in pharma and advice for women entering the industry. What challenges have you faced as a woman in pharma?

Leads 52

Leads Pharma Food and Drug Administration Medicine 52

World of DTC Marketing

JULY 27, 2022

Pharma companies have very little control over patients’ prices for their Rxs. In 2021 pharma provided a staggering $204 billion in price concessions for brand-name medicines to PBMs. It’s gotten so bad that many are asking Congress to step in and do something about it. Let’s take a step back for a minute.

Insurance 226

Insurance Prescription Medicine Medical 226

PharmaKinnex

AUGUST 23, 2022

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. What are these new and existing pharma regulations, expectations, and challenges? COVID-19, Telemedicine, & The New Pharma Landscape.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

pharmaphorum

NOVEMBER 11, 2022

As part of our Women in Pharma series, where we talk to leading figures in the life sciences, we hear from ?eyda This resulted in a change in career path towards pharma, beginning with a role as a marketing professional at Baxter. The post Spotlight on women in pharma: ?eyda eyda Atadan Memi?, eyda Atadan Memi?,

Pharma 82

Pharma Medicine Marketing Management 82

European Pharmaceutical Review

OCTOBER 20, 2022

1 The last four are produced at separate plants and thus less discussed for pharma since they are unlikely to be producing them in house. Water quality from an Annex 1 and Pharma 4.0 Making the journey to PAT and Pharma 4.0. Chemie Ingenieur Technik , 2016, Årg. The post An Annex 1 and Pharma 4.0 perspective.

Food and Drug Administration 85

Food and Drug Administration Pharma Manufacturing Food 85

World of DTC Marketing

APRIL 7, 2021

QUICK READ: The compensation for pharma CEOs is starting to be reported and it’s off the charts. Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Food and Drug Administration between 2010 and 2016 yet did taxpayers receive any discount?

Healthcare 162

Healthcare Healthcare Food and Drug Administration Pharma 162

World of DTC Marketing

SEPTEMBER 9, 2021

If pharma is a business, they will find a way to develop, buy, or acquire new drugs. Across America’s acute care hospitals, total revenues exceeded expenses by more than $64 billion in 2016, according to a Center for American Progress analysis. Then there is the cost of unhealthy Americans.

Healthcare 222

Healthcare Healthcare Government Insurance 222

MedCity News

OCTOBER 12, 2022

Moderna and Merck have been partners in the development of messenger RNA cancer vaccines since 2016. Merck is deepening the alliance by exercising an option that enables it to share equally in further work on a partnered cancer vaccine for melanoma.

Biopharma 99

Biopharma Pharma 99

World of DTC Marketing

DECEMBER 15, 2020

Although only 17% of the population, the 65-plus demographic accounts for more than 30% of all doctor’s visits in the United States; in 2016, people age 65 and up made 80% more office visits than the average number of visits among the general US population. Pharma’s content needs to focus on helping patients rather than selling them.

Doctors 309

Doctors Physicians Patients Pharma 309

World of DTC Marketing

DECEMBER 10, 2021

When George Scangos resigned in 2016, he must have known that the future was bleak. Biogen went from being agile biotech to big pharma. The company could lay off as many as 1,000 employees as it deals with the controversial treatment. The company was riding high on their MS drugs, but the competition was on the way.

Training 231

Training Side effects Consulting Media 231

Penrod

JUNE 6, 2024

To some extent, this patient model fits the requirements of med dev and pharma pretty well, but it wasn’t one-size-fits-all. The main features aim to improve how med dev and pharma companies conduct commercial and clinical operations. What use cases will Life Sciences Cloud Solve?

CRM 52

CRM Food and Drug Administration Healthcare Provider Management 52

Pharma Leaders

MARCH 30, 2023

Nordic pharma company Navamedic ASA has offered $7.2m (SEK75m) to purchase all shares in Sweden-based pharmaceutical firm Sensidose AB. Sensidose has carried out sales in Sweden since the end of 2016, as well as in Norway and Denmark since 2018. The independent bid committee of Sensidose has recommended the cash offer.

Distribution 52

Distribution Marketing Medicine Pharma 52

pharmaphorum

SEPTEMBER 14, 2022

Baumann has been at the helm of Bayer since May 2016, when he took over from Marijn Dekkers, and has spent his entire career at Bayer, rising through the ranks of the company. Bayer has declined to comment on the rumours. The post Report claims Bayer is already hunting for a new CEO appeared first on.

Pharma 79

Pharma Management Leads Marketing 79

pharmaphorum

JULY 22, 2022

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. Pfizer and Flynn have both said they will appeal the new judgment, suggesting this case could drag on yet again.

Competition 100

Competition Pharma Marketing Patients 100

World of DTC Marketing

JUNE 1, 2021

With a lot of money pouring in from MS drugs, their CEO decided that they needed to act like big pharma and moved the company to downtown Cambridge under the guise that it was necessary to get closer to biomedical R&D. At one point, Biogen was down as an innovative biotech company in Weston, Massachusetts.

FDA 187

FDA Side effects Patients Doctors 187

Clarivate

NOVEMBER 11, 2021

The following article summarizes key findings from the latest CIRS R&D Briefing, Review of HTA outcomes and timelines in Australia, Canada and Europe 2016-202 0. This global reduction in the number of NAS appraisals had not been observed previously between 2016 to 2019, and so may be related to the COVID-19 pandemic.

Medicine 52

Medicine Marketing Pharmaceutical Patients 52

pharmaphorum

OCTOBER 26, 2022

Drugmakers Pfizer and Flynn Pharma have formally launched an appeal against a £70 million ($84 million) fine levied by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. The CAT typically takes around nine months to deliver a verdict, although it can take longer in more complicated cases.

Competition 99

Competition Marketing Pharma Medicine 99

PM360

JANUARY 25, 2023

Spurred into action by the pandemic, many pharma brands are undertaking or accelerating their digital transformations. As a relative newcomer to pharma (I joined the industry in 2019), several things stand out about the industry’s approach to digital. There are a few key differences in pharma that made this happen. Consider IPG.

Media 96

Media Digital Media Marketing Pharma 96

Pharmaceutical Technology

NOVEMBER 21, 2022

Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio. The OPIR report showed that Japan's pricing policy has raised serious concern among large multinational pharmaceutical companies, which are wary of a potentially lower return on investment.

Marketing 69

Marketing Leads Pharmaceutical Manufacturing 69

Pharmaceutical Technology

MARCH 24, 2023

However, it has taken over six years for Amjevita to launch, after first being FDA-approved in 2016. Many other biosimilars have also been FDA-approved since 2016. Many pharma companies hold extensive patent protections and have ongoing patent litigation cases. For example, AbbVie had obtained more than 100 patents for Humira.

Competition 59

Competition Marketing FDA Physicians 59

World of DTC Marketing

OCTOBER 27, 2020

Our healthcare system makes too much money for insurers, PBM’s and pharma companies to change. In 2016, consumers told Aflac that enrolling in health insurance should feel like an experience on Amazon. It’s simple: people trust each other more than pharma companies who they view with a high degree of skepticism.

Healthcare 230

Healthcare Healthcare Insurance Retail 230

Pharmaceutical Technology

APRIL 17, 2023

The US Food and Drug Administration (FDA) granted Eli Lilly’s Lartruvo (olaratumab) accelerated approval in 2016 for soft tissue sarcoma (STS). If the Australian pharma company can demonstrate a renewed potential for the drug, Lilly could receive up to $255m in commercial and regulatory milestone payments.

Food and Drug Administration 52

Food and Drug Administration Food Safety FDA 52

Pharmaceutical Technology

OCTOBER 3, 2022

Myovant Sciences has rejected an acquisition offer worth $2.5bn from Sumitovant Biopharma and its wholly-owned subsidiary Sumitomo Pharma, citing it 'significantly undervalues' the company. Established in 2016, Myovant conducted five successful Phase III clinical trials in oncology and women’s health. for each share in cash.

Food and Drug Administration 52

Food and Drug Administration Specialization Biopharma Food 52

pharmaphorum

JULY 13, 2022

Roche isn’t the only big pharma partner Bicycle has attracted for its bicyclic peptide technology. In 2016 it started a $1 billion alliance with AstraZeneca to find drug candidates that could be used to treat respiratory diseases, and extended that in 2018 to include cardiovascular and metabolic disorders.

Leads 87

Leads Manufacturing Pharma 87

Pharmaceutical Technology

NOVEMBER 21, 2022

Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio. The OPIR report showed that Japan's pricing policy has raised serious concern among large multinational pharmaceutical companies, which are wary of a potentially lower return on investment.

Leads 52

Leads Pharmaceutical Marketing Manufacturing 52

Pharmaceutical Technology

SEPTEMBER 2, 2022

increase over the 2016–2020 period average. This is where partners such as Abacus Medicine Pharma Services can really help,” says Simon Estcourt, managing director of Abacus Medicine Pharma Services. The range of services offered by Abacus Medicine Pharma Services’ Commercial Partnerships team provides solutions at every stage.

Food and Drug Administration 52

Food and Drug Administration Pharma Medicine Distribution 52

pharmaphorum

NOVEMBER 6, 2017

The Cancer Vanguard is a bold initiative setup to take leadership in the delivery of the National Cancer Strategy – Achieving World-Class Cancer Outcomes published in 2015 with a key aim of designing and implementing new and increasingly patient centric models of care in Cancer that can benefit and be adopted by the wider national cancer system.

Medicine 52

Medicine Pharma Patients Leads 52

Pharma Marketing Network

MAY 6, 2023

Crown, 2016. (3) The post The Ethical Challenges for Pharmaceutical Marketers in Using AI to Write Marketing Copy or Creative appeared first on Pharma Marketing Network. Harvard Business Review, vol. 7/8, 2018, pp. 2) O’Neil, C. Weapons of Math Destruction: How Big Data Increases Inequality and Threatens Democracy.” Floridi, L.

Ethics 52

Ethics Marketing Pharmaceutical Training 52